Definitive Healthcare Corp
NASDAQ:DH
Definitive Healthcare Corp
Cash & Cash Equivalents
Definitive Healthcare Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
D
|
Definitive Healthcare Corp
NASDAQ:DH
|
Cash & Cash Equivalents
$131m
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Veeva Systems Inc
NYSE:VEEV
|
Cash & Cash Equivalents
$703.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash & Cash Equivalents
$175.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash & Cash Equivalents
$192.8m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash & Cash Equivalents
$158m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Cash & Cash Equivalents
$235m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
See Also
What is Definitive Healthcare Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
131m
USD
Based on the financial report for Dec 31, 2023, Definitive Healthcare Corp's Cash & Cash Equivalents amounts to 131m USD.
What is Definitive Healthcare Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
74%
Over the last year, the Cash & Cash Equivalents growth was -11%. The average annual Cash & Cash Equivalents growth rates for Definitive Healthcare Corp have been 74% over the past three years .